314 filings
Page 12 of 16
8-K
zumrao1xb4g4bq0je6
21 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
8gpwwv
15 Mar 17
Conatus Pharmaceuticals Reports 2016 Financial Results and Program Updates
12:00am
8-K
sh611m zw
17 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
v4jr16plphby4pbqve
16 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
u46qevm 7gdg
7 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
gvxfobl
1 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
0g1mcbga
26 Jan 17
Termination of a Material Definitive Agreement
12:00am
8-K
9hf8fp
19 Dec 16
Conatus Announces Exclusive Worldwide Option, Collaboration and License Agreement Covering Development and Commercialization of Emricasan
12:00am
8-K
b255 etzrh4
19 Dec 16
Termination of a Material Definitive Agreement
12:00am
8-K
9gjfypb9g t1q8iu
8 Nov 16
Conatus Pharmaceuticals Reports Third Quarter 2016 Financial Results and Program Updates
12:00am
8-K
h34j1efgv
3 Aug 16
Conatus Pharmaceuticals Reports Second Quarter 2016 Financial Results and Program Updates
12:00am
8-K
7q2950bqpyqly4jwvk2b
24 Jun 16
Departure of Directors or Certain Officers
12:00am
S-8
7t7cxf
5 May 16
Registration of securities for employees
12:00am
8-K
ebanr
5 May 16
Conatus Pharmaceuticals Reports First Quarter 2016 Financial Results and Program Updates
12:00am